Development and Validation of a Risk Score for Mild Cognitive Impairment in Individuals with Type 2 Diabetes in China: A Practical Cognitive Prescreening Tool.

Authors:
Ding Q; Yu C; Xu X; Hou Y; Miao Y and 5 more

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2024

DOI:
10.2147/DMSO.S448321

PMCID:
PMC10926865

PMID:
38469108

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Diabetes Metab Syndr Obes

Detailed journal information not available.

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Disclosure The authors report no conflicts of interest in this work."

Funding Disclosure

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China Grant Awards (82030026, 81770819, 82000775, 82270883); the Key Research and Development Program of Jiangsu Province of China (BE2022666); the Natural Science Foundation of Jiangsu Province of China (BK20200114); and Fundings for Clinical Trails from the Affiliated Drum Tower Hospital, Medical School, Nanjing University (2022-LCYJ-ZD-03, and 2022-LCYJ-PY-02)."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025